Mablink Bioscience is a biotechnology company developing the next generation of antibody-drug conjugates (ADCs) for cancer treatment, utilizing patented hydrophilic drug-linker technology to enhance drug efficacy and tolerability
Mablink Bioscience is a biotechnology company developing the next generation of antibody-drug conjugates (ADCs) for cancer treatment, utilizing patented hydrophilic drug-linker technology to enhance drug efficacy and tolerability.